5
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus

Pages 11-24 | Published online: 10 Jul 2009

References

  • Adler H, Beland JL, Del-Pan NC, Kobzik L, Sobel RA, Rimm IJ (1999). In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. I Neuroimmunol 93: 208–213.
  • Ahmad A, Menezes J (1996). Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals. Aids 10: 143–149.
  • Anderson MG, Hauer D, Sharma DP, bag SV, Narayan O, Zink MC, Clements JE (1993). Analysis of envelope changes acquired by SIVmac239 during neuroadap-tion in rhesus macaques. Virology 195: 616–626.
  • Bariou C, Genetet N, Ruffault A, Michelet C, Cartier F, Genetet B (1997). Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection. AIDS Res Hum Retroviruses 13: 1301–1312.
  • Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royald W, Dal Pan GJ, McArthur JC (1998). Variable progression of HIV-associated dementia. Neurology 50: 1814–1820.
  • Bruunsgaard H, Pedersen C, Skinhoj P, Pedersen BK (1997). Clinical progression of HIV infection: role of NK cells. Scand I Immunol 46: 91–95.
  • Budka H (1989). Human immunodeficiency virus (HIV)-induced disease of the central nervous system: pathology and implications for pathogenesis. Acta Neuropathol 77: 225–236.
  • Carmichael A, Jin X, Sissons P. Borysiewicz L (1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177: 249–256.
  • Carter DL, Shieh TM, Blosser RL, Chadwick KR, Margolick JB, Hildreth JE, Clements JE, Zink MC (1999). CD56 identifies monocytes and not natural killer cells in rhesus macaques. Cytometry 37 (Suppl): 41–50.
  • Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998). Induction of monocyte chemoattractant protein-I in 1-1IV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95: 3117–3121.
  • Fitzgerald PA, von Wussow P, Lopez C (1982). Role of interferon in natural kill of HSV-I-infected fibroblasts. I Immunol 129: 819–823.
  • Fitzgerald-Bocarsly P, Feldman M, Mendelsohn M, Curl S, Lopez C (1988). Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. I Leukoc Biol 43: 323–334.
  • Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE (1997). Molecular and biological char-acterization of a neurovirulent molecular clone of SIV. I Virol 71: 5790–5798.
  • Heinkelein M, Sopper S. Jassoy C (1995). Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells. I Virol 69: 6925–6931.
  • Flidore MR, Nabavi N, Sonleitner F, Murphy JW (1991). Murine natural killer cells are fungicidal to Crypto-coccus neoformans. Infect Immun 59: 1747–1754.
  • Flinch VM, Fuerst TR, Sutter G, Carroll MW, Yang LC, Goldstein S, Piatak M, Elkins WR, Alvord WG, Montefiori DC, Moss B, Lifson JD (1996). Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. I Virol 70: 3741–3752.
  • Howell DM, Feldman M, Siegal FP, Pettera L, Fitzgerald-Bocarsly P (1993). Peripheral blood of AIDS patients contains cells capable of providing accessory function for the natural killer cell-mediated, lysis of herpes simplex virus-infected targets despite low interferon-alpha production. I Acquir Immune Defic Syndr 6: 15–23.
  • Howell DM, Fitzgerald-Bocarsly P (1991). Natural killer-mediated lysis of some but not all HSV-I- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells. Immunology 72: 443–447.
  • Jin X, Wills M, Sissons JG, Carmichael A (1998). Progressive loss of IL-2-expandable HIV-I-specific cytotoxic T lymphocytes during asymptomatic HIV infection. Eur I Immunol 28: 3564–3576.
  • Johnson RM, Lancki DW, Sperling Al, Dick RF, Spear PG, Fitch FW, Bluestone JA (1992). A murine CD4-, CD8-T cell receptor-gamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein I. I Immunol 148: 983–988.
  • Kelder W, McArthur JC, Nance-Sproson T, Lanier R, Griffin DE (1998). B-chemokines MCP-1 and RANTES are increased in cerebrospinal fluid of patients with HIV-associated dementia. Annals of Neurol 44: 831–835.
  • Levitz SM, Dupont MP (1993). Phenotypic and func-tional characterization of human lymphocytes acti-vated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro. I Clin Invest 91: 1490–1498.
  • McArthur I, Hoover D, Bacellar H, Miller E, Cohen B, Becker J, Graham N, McArthur J, Selnes O, Jacobson L, Visscher B, Concha M, Saah S (1993). Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245–2253.
  • McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relation-ship between human immunodeficiency virus-asso-ciated dementia and viral load in cerebrospinal fluid and brain [see comments]. Ann Neurol 42: 689–698.
  • Murphy JW (1993). Natural killer cells and Cryptococcus neoformans. Adv Exp Med Biol 335: 269–275.
  • Murphy JW, Hidore MR, Wong SC (1993). Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. I Clin Invest 91: 1553–1566.
  • Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Thai Q-Ft Sharer LR, McComb D, Swindells S, Soderland C, Gendelman HG (1996). Mechanisms for the transendothelial migration of HIV-I-infected monocytes into brain. I Immunol 156: 1284–1295.
  • Ohnimus H, Heinkelein M, Jassoy C (1997). Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses C1i95 (Fas/Apo-I) and TNF receptor 1. I Immunol 159: 5246–5252.
  • Paya CV, Patick AK, Leibson PJ, Rodriguez M (1989). Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. I Immunol 143: 95–102.
  • Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. I Immunol 158: 3499–3510.
  • Poquet Y, Constant P, Halary F, Peyrat MA, Gilleron M, Davodeau F, Bonneville M, Fournie JJ (1996). A novel nucleotide-containing antigen for human blood gam-ma delta T lymphocytes. Eur I Immunol 26: 2344–2349.
  • Schwartz SA, Nair MP (1997). Molecular mechanisms in the pathogenesis of AIDS encephalopathy. Cell Mol Biol (Noisy-le-grand) 43: 925–933.
  • Sciammas R, Bluestone JA (1998). HSV-I glycoprotein I-reactive TCR gamma delta cells directly recognize the peptide backbone in a conformationally dependent manner. I Immunol 161: 5187–5192.
  • See DM, Khemka P, Sahl L, Bui T, Tilles JG (1997). The role of natural killer cells in viral infections. Scand I Immunol 46: 217–224.
  • Suryanarayana K, Wiltrout KA, Vasquez GM, Hirsch VM, Lifson JD (1998). Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction. AIDS Res Hum Retroviruses 14: 183–189.
  • Tyler DS, Nastala CL, Stanley SD, Matthews TJ, Lyerly HK, Bolognesi DP, Weinhold KJ (1989). GP120 specific cellular cytotoxicity in 1-1IV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody. I Immunol 142: 1177–1182.
  • Ullum H, Cozzi Lepri A, Aladdin H, Katzenstein T, Victor J, Phillips AN, Gerstoft J, Skinhoj P. Klarlund Pedersen B (1999). Natural immunity and HIV disease progression [In Process Citation]. Aids 13: 557–563.
  • Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P. Pedersen BK (1995). Defective natural immunity: an early manifestation of human immunodeficiency virus infection. I Exp Med 182: 789–799.
  • Vowels BR, Gershwin ME, Gardner MB, McGraw TP (1990). Natural killer cell activity of rhesus macaques against retrovirus-pulsed CD4+ target cells. AIDS Res Hum Retroviruses 6: 905–918.
  • Welsh RM (1986). Regulation of virus infections by natural killer cells. A review. Nat Immun Cell Growth Regul 5: 169–199.
  • Yamamoto H, Miller MD, Watkins DI, Snyder GB, Chase NE, Mazzara GP, Gritz L, Panicali DL, Letvin NL (1990). Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. I Immunol 145: 3740–3746.
  • Yin C, Wu MS, Pauza CD, Salvato MS (1999). High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression [In Process Citation]. I Virol 73: 3692–3701.
  • Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak Jr M, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE (1999). High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. I Virol 73: 10480–10488.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.